Investors / United States / ARTIS
ARTIS
Venture capital · San Francisco, CA, United States · North America
ARTIS is an investment firm that supports founders applying frontier technologies to health and the human condition. It backs companies working across areas such as AI, medical devices, fertility, longevity, cancer therapeutics, radiology AI and microbiome science.
Invests inHealthcare & Biotech
In its own wordshealthaibiotechmedical devicesfertilitylongevity
Your fit with ARTIS
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsARTIS lists 53 checked portfolio companies on its own site and is named in 11 funding rounds, 1 of them as lead. Its most frequent entry is Series A, 46% of the companies with a known first round. Its largest themes are Healthcare & Biotech (66%), AI & Machine Learning (9%) and Enterprise Software (9%). 94% of its companies are based in United States. It invests most often alongside Abstract, Civilization Ventures and Evolution VC Partners.
Counts come from funding rounds that name ARTIS, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not ARTIS' whole history. Rounds on record name 11 companies; its own site lists 53. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundARTIS does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 9% |
| Series A | 46% |
| Series B | 27% |
| Growth | 18% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 1 | 0 |
| '25 | 2 | 0 |
| '26 | 8 | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 85th | 53 companies |
| Recent activity | 93th | 8 rounds in 12 months |
| Early stage | 55th | 9% of entries at pre-seed or seed |
| Evidence | 89th | 17% of companies confirmed by a round |
| Sector focus | 90th | 66% in its largest sector |
| Reach | 59th | 3 countries |
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 66% | 15% |
| AI & Machine Learning | 9% | 18% |
| Enterprise Software | 9% | 8% |
| Industrial & Manufacturing | 3% | 7% |
| Food & Agriculture | 3% | 3% |
| Cybersecurity | 3% | 4% |
| Consumer | 2% | 3% |
| Legal & Compliance | 2% | 2% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Abstract | 7 |
| Civilization Ventures | 5 |
| Evolution VC Partners | 4 |
| Modi Ventures | 4 |
| NEA | 4 |
| OMX Ventures | 4 |
| 8VC | 3 |
| Andreessen Horowitz | 3 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers5298%
- No longer answers00%
- Points to another company12%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherCompare ARTIS head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
from public registers and its siteRecent portfolio activity
when companies last raised with ARTIS| Date | Company | Stage |
|---|---|---|
| 9 Nov 2026 | Series C+ | |
| 29 Oct 2026 | Series B | |
| 8 Sept 2026 | Series A | |
| 27 Aug 2026 | Series A | |
| 7 Jul 2026 | Seed | |
| 15 Apr 2026 | Series A Led | |
| 16 Mar 2026 | Series B | |
| 7 Jan 2026 | Series A |
Round details for ARTIS
Amounts, full round histories and every co-investor in ARTIS' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
53 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Portfolio page | ||||
| YouTube provides a platform for creators to share their stories and build community through video content. | Enterprise SoftwareMedia & Entertainment | Portfolio page | ||
| Activ Surgical develops and provides real-time surgical intelligence for surgeons and platforms | Healthcare & Biotech | Portfolio page | ||
| Aether Bio discovers proteins with high-impact applications, including building super materials and processing critical minerals, using artificial intelligence and robotic high-throughput screening labs. | AI & Machine LearningIndustrial & Manufacturing | Portfolio page | ||
| Affect Therapeutics provides mental health and addiction treatment services. | Healthcare & Biotech | Portfolio page | ||
| AllIn Bio develops a precision immunology approach to treating chronic inflammatory disease | Healthcare & Biotech | Portfolio page | ||
| Arkenstone provides infrastructure for federal contracting, compliance, HR, and contracting for technology companies, particularly those in the national security ecosystem. | Industrial & ManufacturingAI & Machine Learning | Jul 2026Seed | Page + round | |
| Bettani produces dairy-free cheese alternatives with high protein content | Food & Agriculture | Portfolio page | ||
| Bloom Energy provides onsite energy solutions, including power generation and distribution systems, to various industries. | EducationHealthcare & Biotech | Portfolio page | ||
| Cartography Biosciences is developing molecules that are lethal to cancer and safe for patients by analyzing massive datasets from individual human cells. | Healthcare & Biotech | Oct 2025Series B | Page + round | |
| Portfolio page | ||||
| Conceivable Life Sciences develops and uses automation-assisted IVF lab technology to improve reproductive medicine outcomes. | Healthcare & Biotech | Sept 2025Series A | Page + round | |
| Delfina provides personalized pregnancy care solutions to individuals and families through a connected care platform and mobile app. | Healthcare & Biotech | Portfolio page | ||
| Delix Therapeutics is developing novel therapeutics to address brain health challenges | Healthcare & Biotech | Nov 2026Series C+ | Page + round | |
| Doctronic provides online medical consultations and treatment plans based on peer-reviewed medical research | Healthcare & Biotech | Portfolio page | ||
| Eko creates digital stethoscopes and provides AI disease detection and telehealth solutions | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| Fig is an app that shows users what foods they can eat based on their dietary needs and restrictions | Food & AgricultureHealthcare & Biotech | Portfolio page | ||
| Freenome develops blood-based screening tests to detect cancer at its earliest stages | Healthcare & Biotech | Feb 2024Series C+ | Page + round | |
| GenHealth.ai provides medical billing automation and services for revenue cycle management powered by US billers and AI | Healthcare & Biotech | Sept 2026Series A | Funding round |
About this data
site last read 5 Nov 2026- Site
- av.co
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 15 Feb 2024
- Companies checked
- 53
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get ARTIS' profile as data
Pull ARTIS' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/av.co
# also
GET /v1/firms/av.co/portfolio
GET /v1/firms/av.co/coinvestors
GET /v1/firms/av.co/news